A small tool to view real-world ActivityPub objects as JSON! Enter a URL
or username from Mastodon or a similar service below, and we'll send a
request with
the right
Accept
header
to the server to view the underlying object.
{
"@context": [
"https://www.w3.org/ns/activitystreams",
{
"ostatus": "http://ostatus.org#",
"atomUri": "ostatus:atomUri",
"inReplyToAtomUri": "ostatus:inReplyToAtomUri",
"conversation": "ostatus:conversation",
"sensitive": "as:sensitive",
"toot": "http://joinmastodon.org/ns#",
"votersCount": "toot:votersCount",
"Hashtag": "as:Hashtag"
}
],
"id": "https://beta.argyle.social/users/auditorynerves/statuses/113896032506889271",
"type": "Note",
"summary": null,
"inReplyTo": null,
"published": "2025-01-26T18:18:55Z",
"url": "https://beta.argyle.social/@auditorynerves/113896032506889271",
"attributedTo": "https://beta.argyle.social/users/auditorynerves",
"to": [
"https://www.w3.org/ns/activitystreams#Public"
],
"cc": [
"https://beta.argyle.social/users/auditorynerves/followers"
],
"sensitive": false,
"atomUri": "https://beta.argyle.social/users/auditorynerves/statuses/113896032506889271",
"inReplyToAtomUri": null,
"conversation": "tag:beta.argyle.social,2025-01-26:objectId=10793:objectType=Conversation",
"content": "<p>"Breakthrough drugs herald ‘new era’ in battle against dementia"</p><p>Medical advances make pills to treat Alzheimer’s disease viable, though challenges remain in sharing gains globally.</p><p>Currently 127 drugs in trials for Alzheimer’s disease.</p><p>🧪🧠💊 <a href=\"https://beta.argyle.social/tags/neuroskyence\" class=\"mention hashtag\" rel=\"tag\">#<span>neuroskyence</span></a></p><p>www.theguardian.com/global-devel...<br /><a href=\"https://www.theguardian.com/global-development/2025/jan/08/health-medicine-new-era-drugs-dementia-alzheimers-disease-pharmaceuticals-lecanemab-donanemab\" target=\"_blank\" rel=\"nofollow noopener noreferrer\"><span class=\"invisible\">https://www.</span><span class=\"ellipsis\">theguardian.com/global-develop</span><span class=\"invisible\">ment/2025/jan/08/health-medicine-new-era-drugs-dementia-alzheimers-disease-pharmaceuticals-lecanemab-donanemab</span></a></p>",
"contentMap": {
"en": "<p>"Breakthrough drugs herald ‘new era’ in battle against dementia"</p><p>Medical advances make pills to treat Alzheimer’s disease viable, though challenges remain in sharing gains globally.</p><p>Currently 127 drugs in trials for Alzheimer’s disease.</p><p>🧪🧠💊 <a href=\"https://beta.argyle.social/tags/neuroskyence\" class=\"mention hashtag\" rel=\"tag\">#<span>neuroskyence</span></a></p><p>www.theguardian.com/global-devel...<br /><a href=\"https://www.theguardian.com/global-development/2025/jan/08/health-medicine-new-era-drugs-dementia-alzheimers-disease-pharmaceuticals-lecanemab-donanemab\" target=\"_blank\" rel=\"nofollow noopener noreferrer\"><span class=\"invisible\">https://www.</span><span class=\"ellipsis\">theguardian.com/global-develop</span><span class=\"invisible\">ment/2025/jan/08/health-medicine-new-era-drugs-dementia-alzheimers-disease-pharmaceuticals-lecanemab-donanemab</span></a></p>"
},
"attachment": [],
"tag": [
{
"type": "Hashtag",
"href": "https://beta.argyle.social/tags/neuroskyence",
"name": "#neuroskyence"
}
],
"replies": {
"id": "https://beta.argyle.social/users/auditorynerves/statuses/113896032506889271/replies",
"type": "Collection",
"first": {
"type": "CollectionPage",
"next": "https://beta.argyle.social/users/auditorynerves/statuses/113896032506889271/replies?only_other_accounts=true&page=true",
"partOf": "https://beta.argyle.social/users/auditorynerves/statuses/113896032506889271/replies",
"items": []
}
}
}